|

UnitedHealth stock surges on Trump election win

  • UNH stock jumps more than 6% on Trump presidential election win.
  • Health insurers that manage Medicare Advantage programs saw their share prices rise.
  • The Biden administration has been attempting to lower reimbursement rates for senior healthcare.
  • Companies focused on Medicaid care swung to losses as Republicans are less favorable to the poor.

UnitedHealth Group (UNH), the single largest weighting in the Dow Jones Industrial Average (DJIA), has risen about 6% on Wednesday in light of Donald Trump’s reelection to the US presidency. 

Though states are continuing to count the outstanding vote, Trump has secured enough electoral votes to ensure his rise to the 47th presidency of the United States, an office he will enter on January 20, 2025. Additionally, his Republican Party has won a majority in the Senate, the upper house of Congress. Control of the House of Representatives, the lower chamber, is still uncertain for now.

The DJIA has surged more than 3% on Wednesday, easily overpowering normally more volatile S&P 500 and NASDAQ indices, which have gained closer to 2% each.

UnitedHealth Group stock news

UnitedHealth stock shot up to just under $600 on Wednesday as a Trump presidency is expected to offer better reimbursement rates for health insurers in the United States. The Biden administration had been strict on reimbursement levels under the Medicare program that pays for healthcare among seniors. In fact, President Biden’s administration has attempted to cut reimbursement rates for Medicare. 

In particular, insurers that run Medicare Advantage programs saw the most gains. These programs are private versions of the government's main government-led enrollment program.

The positivity around a Trump presidency was felt throughout the health insurance industry. CVS Health (CVS), which owns insurer Aetna, bounced 11% higher, but that was a reaction to third-quarter earnings as well. Humana (HUM) stock also advanced at a healthy clip. 

Meanwhile, insurers and healthcare providers like Elevance Health (ELV) and Centene (CNC) that focus on providing care through the government’s Medicaid program that offers healthcare to the lower income segment saw their shares slide.

CVS bested its consensus revenue figure by a wide margin, but the company missed the bottom line consensus due to restructuring charges. The CVS segment that operates Aetna saw revenue of $33 billion, which rose 26% YoY. However, premium deficiency reserves topped $1 billion, which led to a profit loss in the segment.

UnitedHealth Group stock forecast

UnitedHealth stock is nearing resistance at $608. This level was difficult to maintain on September 4 and October 14. There have been other instances in the past two months where rallies dissipated once they rose above $600.

UNH stock has moved lower on Wednesday after reaching an early intraday high of $605.50. Shares sank back to the $590s by mid-session. Expect another attempt at $608 and for UNH to maintain that price level as traders grow excited about a Trump presidency that should reliably be more pro-business and less serious about regulatory matters.

UNH daily stock chart

Premium

You have reached your limit of 3 free articles for this month.

Start your subscription and get access to all our original articles.

Subscribe to PremiumSign In

Author

Clay Webster

Clay Webster

FXStreet

Clay Webster grew up in the US outside Buffalo, New York and Lancaster, Pennsylvania. He began investing after college following the 2008 financial crisis.

More from Clay Webster
Share:

Markets move fast. We move first.

Orange Juice Newsletter brings you expert driven insights - not headlines. Every day on your inbox.

By subscribing you agree to our Terms and conditions.

Editor's Picks

EUR/USD struggles for direction amid USD gains

EUR/USD is trimming part of its earlier gains, coming under some mild downside pressure near 1.1730 as the US Dollar edges higher. Markets are still digesting the Fed’s latest rate decision, while also looking ahead to more commentary from Fed officials in the sessions ahead.

GBP/USD drops to daily lows near 1.3360

Disappointing UK data weighed on the Sterling towards the end of the week, triggering a pullback in GBP/USD to fresh daily lows near 1.3360. Looking ahead, the next key event across the Channel is the BoE meeting on December 18.

Gold losses momentum, challenges $4,300

Gold now gives away some gains and disputes the key $4,300 zone per troy ounce following earlier multi-week highs. The move is being driven by expectations that the Fed will deliver further rate cuts next year, with the yellow metal climbing despite a firmer Greenback and rising US Treasury yields across the board.

Litecoin Price Forecast: LTC struggles to extend gains, bullish bets at risk

Litecoin (LTC) price steadies above $80 at press time on Friday, following a reversal from the $87 resistance level on Wednesday. Derivatives data suggests a bullish positional buildup while the LTC futures Open Interest declines, flashing a long squeeze risk.

Big week ends with big doubts

The S&P 500 continued to push higher yesterday as the US 2-year yield wavered around the 3.50% mark following a Federal Reserve (Fed) rate cut earlier this week that was ultimately perceived as not that hawkish after all. The cut is especially boosting the non-tech pockets of the market.

Aave Price Forecast: AAVE primed for breakout as bullish signals strengthen

Aave (AAVE) price is trading above $204 at the time of writing on Friday and approaching the upper boundary of its descending parallel channel; a breakout from this structure would favor the bulls.